By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    improving patient experience
    6 Ways to Improve Patient Satisfaction Within Hospitals
    December 1, 2021
    degree for healthcare job
    What Are The Health Benefits Of Having A Degree?
    March 9, 2022
    custom software development is changing healthcare
    Digital Customer Journey Mapping and its Importance for Healthcare
    July 21, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Can Thinking Younger Make You Live Longer?
    April 20, 2011
    Image
    Obesity’s Outlook Unchanged
    June 13, 2011
    When It’s An Emergency Elderly Not Treated As Well in Hospitals
    July 16, 2011
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Science for Sale: The Very Sad Case of Medtronic’s “Infuse”
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Science for Sale: The Very Sad Case of Medtronic’s “Infuse”
BusinessMedical DevicesMedical Ethics

Science for Sale: The Very Sad Case of Medtronic’s “Infuse”

psalber
Last updated: October 26, 2012 8:18 am
psalber
Share
7 Min Read
SHARE

Recently, I met with an Israeli naturopath who wanted to crowdfund his products on my new platform, Health Tech Hatch.   After about 20 minutes of discussion, it was clear that this doctor had absolutely no reliable data to support his claims (his product, he said, would improve or cure everything from Type 2 diabetes to psoriasis to retinal detachments – it also helps chickens gain weight faster and be healthy enough to be declared Health Tech Hatch.   After about 20 minutes of discussion, it was clear that this doctor had absolutely no reliable data to support his claims (his product, he said, would improve or cure everything from Type 2 diabetes to psoriasis to retinal detachments – it also helps chickens gain weight faster and be healthy enough to be declared Glatt Kosher).

My husband, an MD, PhD-type and I rather smugly told him we couldn’t possibly promote his ideas on our website unless he subjected his products to rigorous clinical trials.  Publication of the results of those trials in peer-reviewed journals are, after all, the gold standard.

Fast forward to the next day, October 25, 2012.   I am catching up on my email while eating lunch at the Tel Aviv Hilton when this headline on MedPage Today smacks me in the face:  Senate Investigation: Millions Paid for Positive Spin on Spine Fusion Product.   It is a story about Medtronic exerting undue influence (to say the least) on publications about its bone growth product, bone morphogenetic protein-2, whose brand name is “Infuse.” 

According to the MedPage Today story, written by John Fauber, a reporter with Milwaukee Journal Sentinel & MedPage Today,

More Read

Tissue Engineering and Cell Therapy to Grow to Over $30 Billion Global Market
Mobile Devices, Patient Self-monitoring and Clinical Workflow
FDA Fired Device Whistleblowers
Specialty EMR Company Lands $14M to Take on New Markets
Facility Fees for Hospital-Owned Physician Offices: A Nasty Surprise for Patients

”Medtronic employees, including some working in the company’s marketing department, covertly collaborated with the academic physician authors in producing 11 different papers between 2002 and 2009.” 

Evidently, Medtronic employees were editing and in some cases writing parts of  papers that were published in important peer-reviewed journals, even to the point of obfuscating important data that might have been viewed as unfavorable to the product:

 “An email indicated that a Medtronic marketing employee, Julie Bearcroft, was involved in editing a 2005 Journal of Bone and Joint Surgery article and recommended against publishing a complete list complications related to the structural integrity of the fused area.  Those complications — known as implant migration, subsidence and end-plate fracture — had been observed in a clinical trial and had been formatted in a detailed table, according to an internal Medtronic email. But, following the advice of Bearcroft, that table was not included in the published paper.”

Not only that, but the so-called authors of the papers in question were making millions of dollars from their affiliation with the company:

“”The lead author of the paper, Ken Burkus, MD, a Columbus, Ga. surgeon, sent a draft of the paper to his co-authors with the note, “this manuscript documents the superiority in clinical and radiographic outcomes with (Infuse)…” Burkus, who got $6.4 million from Medtronic between 1998 through 2010, did not respond to an email seeking his comment.””

The article states that,

“Over the course of 15 years, Medtronic paid $210 million to a group of 13 doctors who co-authored the series of now-repudiated papers about the product. The payments also included two corporate entities associated with some of the doctors.”

Of course, Medtronic disputes these claims, saying,

“Medtronic vigorously disagrees with any suggestion that the company improperly influenced or authored any of the peer-reviewed published manuscripts discussed in the report, or that Medtronic intended to under-report adverse events…” 

Well, what would you expect them to say?  “Hey, it’s only business [really, really big] business.”

Iron pyrite (aka fool’s gold)

This type of story, sadly, is not new.  Pharma and medical device companies have been helping to write articles for publications for years.  Remember, the Neseritide story?  But what is so distressing is not that it happened, but that it keeps on happening.  And, that it is endangering the integrity and reputation peer-reviewed publications, with the distinct possibility of transforming the gold standard into fool’s gold.

Hey guys, these are just any old products.  They are products that can harm people or, at a minimum, do not help them.  In addition, millions of health care dollars are wasted paying for professionally hyped products that could be used to provide more effective, safer, and in many cases, less expensive treatments to many thousands of patients.

I realize that the word “regulation” is a dirty word in the highly charged atmosphere of a tightly contested election season.  But how else are we going to fix this problem? Clearly, industries as lucrative as medical devices and big pharma have proven themselves incapable of policing themselves.  An unfettered market may be good for profits, but, in my opinion, is not good for patients.  Regulation, independent oversight, financial and criminal penalties need to be brought into play so that companies tempted to cross the line will know there are consequences.

If you have a better idea about how we can curb these type of abuses, I would love to hear it.

The full text of the article under discussion can be found on MedPage Today.

 

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025
Learn how to Renew your Medical Card in West Virginia
Learn how to Renew your Medical Card in West Virginia
Health
May 15, 2025
Dr. Klaus Rentrop Shares Acute Myocardial Infarction heart treatment
Dr. Klaus Rentrop Shares Acute Myocardial Infarction
Cardiology
May 13, 2025

You Might also Like

A Look at Oncology Medication Management

March 4, 2012

Lawmakers Finally Asking About Medicare Contractor Conflict of Interests

March 1, 2011
risk management
BusinesseHealthMedical RecordsPolicy & LawTechnology

Accountability for Risk Management and Cybersecurity in Healthcare Institutions

January 28, 2015

Partnering to Improve Quality and Safety: A Framework for Working with Patient and Family Advisors

September 21, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?